Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. CellSource Co., Ltd.
  6. News
  7. Summary
    4880   JP3423580004

CELLSOURCE CO., LTD.

(4880)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Certain Common Stock of CellSource Co., Ltd. are subject to a Lock-Up Agreement Ending on 24-APR-2020.

04/24/2020 EST

Certain Common Stock of CellSource Co., Ltd. are subject to a Lock-Up Agreement Ending on 24-APR-2020. These Common Stock will be under lockup for 180 days starting from 27-OCT-2019 to 24-APR-2020. Details: In connection with the offering, the lenders, Masato Tsumamoto, Serial Incubation Co., Ltd. which is the shareholder, and Masayuki Yamakawa, have agreed with the lead manager that during the period until April 24, 2020, which is the 180th day after the listing date from the date of the original underwriting contract the Company's shares will not be sold (excluding the lending of the Company's common stock for sale through over-allotment) without the prior written consent of the lead manager.


ę S&P Capital IQ 2020
All news about CELLSOURCE CO., LTD.
2020CELLSOURCE CO., LTD.(TSE : 4880) added to S&P Global BMI Index
CI
2020Certain Common Stock of CellSource Co., Ltd. are subject to a Lock-Up Agreement Ending ..
CI
2019CellSource Co., Ltd. has completed an IPO in the amount of ą1.0944 billion.
CI
2019CellSource Co., Ltd. has filed an IPO.
CI
More news
Financials
Sales 2021 2 904 M 25,4 M 25,4 M
Net income 2021 575 M 5,04 M 5,04 M
Net Debt 2021 - - -
P/E ratio 2021 140x
Yield 2021 -
Capitalization 80 932 M 710 M 709 M
Capi. / Sales 2021 27,9x
Capi. / Sales 2022 21,3x
Nbr of Employees 68
Free-Float -
Chart CELLSOURCE CO., LTD.
Duration : Period :
CellSource Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CELLSOURCE CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 4 345,00 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Masato Tsumamoto President, CEO & Representative Director
Takeshi Amemiya Chief Financial Officer & Director
Katsuji Onishi Executive Officer & GM-Business Administration
Norio Murakami Independent Outside Director
Hirohiko Hanaki Director & Chief Compliance Officer
Sector and Competitors